BioSpace News Archive

Owlstone Medical Ltd. announced today the addition of Dr Andy Richards CBE to its Board as a Non-Executive Director.

The Federal Ministry of Health of Nigeria (Federal Ministry of Health) and BIO Ventures for Global Health (BVGH) convened a Cancer Stakeholder meeting last week under the auspices of BVGH’s African Access Initiative (AAI) to finalize plans for a pilot cancer drug access program to combat Nigeria’s rapidly rising cancer burden.

Regulatory Approvals In-Process; New Record Date to be Set Shortly

QIAGEN to launch two Sample to Insight systems in Europe and other markets, NeuMoDx to commercialize in the U.S. / Initial assay menu for infectious diseases and LDTs

CE-marked workflow enables efficient, high-throughput screening for tuberculosis control efforts in Europe and other markets; introduction in United States expected in 2019 and China in 2020

Building Team to Transform Respiratory Virus Infection Management using Therapeutic Interfering Particles

Believes China Will Realize Intelligent Care and Nursing for Senior Citizens in the Future

Dr Edward Stevens appointed as Head of Drug Discovery, and Dr Andrew Lightfoot as Head of Medicinal Chemistry and Discovery Funding

New Investors SVC, Blue Ocean Ventures, Investiere and B-to-V Participated in the Round with ZKB

Sphere Fluidics today introduced Cyto-Mine® Studio Software Suite, an updated software for its innovative Cyto-Mine Single Cell Analysis System.